---

April 14, 2021

Predictmedix Announces a 2 Year Revenue Contract With Flow Alkaline Spring Water for North American Operations

Toronto, ON / April 14, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a 24 month, multi-unit contract to deploy Safe Entry Stations throughout the North American operations of Flow…

Read full release →

April 05, 2021

Predictmedix and Juiceworks Form Strategic Partnership with Connectus Global to Deploy Safe Entry Stations Nationwide

Toronto, ON / April 5, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a partnership to deploy Safe Entry Stations in partnership with North American industry leaders JUICEWORKS EXHIBITS (JUICEWORKS)…

Read full release →

March 29, 2021

Predictmedix Inc. Announces Engagement of Investment Banking Firm Kingswood Capital Markets

Toronto, ON / March 29, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), a leader in providing AI-powered healthcare solutions is pleased to announce that it has appointed Kingswood Capital Markets (“Kingswood”) in preparation…

Read full release →

March 23, 2021

Predictmedix Announces LOI to Acquire SYMP2PASS INC

TORONTO, March 23, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce it has entered into a letter of intent (the “LOI”), to acquire Symp2Pass Inc. (“Symp2pass”) (the “Acquisition”). The LOI…

Read full release →

March 05, 2021

Predictmedix Inc. Secures Strategic Financing to Catalyze Operations

Toronto, ON / March 5, 2021/ Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to provide a corporate update on its recent activities. The Company is proud to announce that it has closed a non-brokered private…

Read full release →